ARCHIVES

FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC.

This article is from The Cancer Letter archive.

Vol. 27 No. 13 | March 30, 2001

Download PDF Visit The Full Archive

Related Articles

In Brief: Nutrition Research Intrigues Investigators After All; Advisory Committee Being Formed

March 7, 1975

MSK, Fox Chase Volunteer to Limit Their Core Grants To Let Others Grow

June 29, 1990

NCI Will Get $1.3 Billion, But Only If Congress Fends Off GRH Cuts, Reprogramming For Drug War

October 3, 1986

MRI Effective For Women With BRCA Gene Mutations

September 24, 2004

COG’s Peter Adamson Has A Conversation With The Cancer Letter

March 15, 2013

Funding Opportunities.

May 10, 2002